Authors: Reuland, P Geiger, L Thelen, MH Handgretinger, R Haase, B Muller-Schauenburg, W Niethammer, D Bares, R

Citation: P. Reuland et al., Follow-up in neuroblastoma: Comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response, J PED H ONC, 23(7), 2001, pp. 437-442

Authors: Bilger, K Kupferschlager, J Muller-Schauenburg, W Nusslin, F Bares, R

Citation: K. Bilger et al., Threshold calculation for segmented attenuation correction in PET with histogram fitting, IEEE NUCL S, 48(1), 2001, pp. 43-50

Authors: Bares, R Muller-Schauenburg, W

Citation: R. Bares et W. Muller-schauenburg, Nuclear medicine procedures to diagnose renal disorders, RADIOLOGE, 40(10), 2000, pp. 938-945

Authors: Helber, U Muller, M Muller-Schauenburg, W Hoffmeister, HM

Citation: U. Helber et al., (201)Thallium ECT perfusion pattern in dilated cardiomyopathy, PERFUSION, 12(8), 1999, pp. 321

Authors: Piert, M Winter, E Becker, GA Bilger, K Machulla, HJ Muller-Schauenburg, W Bares, R Becker, HD

Citation: M. Piert et al., Allogenic bone graft viability after hip revision arthroplasty assessed bydynamic [F-18]fluoride ion positron emission tomography, EUR J NUCL, 26(6), 1999, pp. 615-624